Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/88524
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Land Surveying and Geo-Informatics | - |
dc.creator | Pan, XF | - |
dc.creator | Kaminga, AC | - |
dc.creator | Jia, P | - |
dc.creator | Wen, SW | - |
dc.creator | Acheampong, K | - |
dc.creator | Liu, AZ | - |
dc.date.accessioned | 2020-11-27T05:50:05Z | - |
dc.date.available | 2020-11-27T05:50:05Z | - |
dc.identifier.uri | http://hdl.handle.net/10397/88524 | - |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Research Foundation | en_US |
dc.rights | Copyright © 2020 Pan, Kaminga, Jia, Wen, Acheampong and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | en_US |
dc.rights | The following publication Pan, X. F., Kaminga, A. C., Jia, P., Wen, S. W., Acheampong, K., & Liu, A. Z. (2020). Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience, 12, 184, 1-12 is available at https://dx.doi.org/10.3389/fnagi.2020.00184 | en_US |
dc.subject | Catecholamines | en_US |
dc.subject | Dopamine | en_US |
dc.subject | Epinephrine | en_US |
dc.subject | Norepinephrine | en_US |
dc.subject | Alzheimer'S disease | en_US |
dc.subject | Meta-Analysis | en_US |
dc.title | Catecholamines in alzheimer's disease : a systematic review and meta-analysis | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.spage | 1 | - |
dc.identifier.epage | 12 | - |
dc.identifier.volume | 12 | - |
dc.identifier.doi | 10.3389/fnagi.2020.00184 | - |
dcterms.abstract | Background and Purpose:Previous studies found inconsistent results regarding the relationship between Alzheimer's disease (AD) and catecholamines, such as dopamine (DA), norepinephrine (NE), and epinephrine (EPI). Therefore, the Purpose: of this study was to perform a systematic review and meta-analysis to evaluate the results of previous studies on this relationship. | - |
dcterms.abstract | Method: Literature retrieval of eligible studies was performed in four databases (Web of Science, PubMed, Embase, and PsycARTICLES). Standardized mean differences (SMDs) were calculated to assess differences in catecholamine concentrations between the AD groups and controls. | - |
dcterms.abstract | Results: Thirteen studies met the eligibility criteria. Compared with the controls, significant lower concentrations of NE (SMD = -1.10, 95% CI: -2.01 to -0.18,p= 0.019) and DA (SMD = -1.12, 95% CI: -1.88 to -0.37,p= 0.003) were observed in patients with AD. No difference was found in the concentrations of EPI between the two groups (SMD = -0.74, 95% CI: -1.85 to 0.37,p= 0.189). | - |
dcterms.abstract | Conclusion: Overall, these findings are in line with the hypothesis that reduced NE and DA may be an important indicator for AD (Registration number CRD42018112816). | - |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | Frontiers in aging neuroscience, 2020, v. 12, 184, p. 1-12 | - |
dcterms.isPartOf | Frontiers in aging neuroscience | - |
dcterms.issued | 2020-09 | - |
dc.identifier.isi | WOS:000575638100001 | - |
dc.identifier.scopus | 2-s2.0-85091591410 | - |
dc.identifier.pmid | 33024430 | - |
dc.identifier.eissn | 1663-4365 | - |
dc.identifier.artn | 184 | - |
dc.description.validate | 202011 bcrc | - |
dc.description.oa | Version of Record | en_US |
dc.identifier.FolderNumber | OA_Scopus/WOS | en_US |
dc.description.pubStatus | Published | en_US |
dc.description.oaCategory | CC | en_US |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pan_Catecholamines_Alzheimer_Disease.pdf | 2.24 MB | Adobe PDF | View/Open |
Page views
56
Last Week
0
0
Last month
Citations as of Oct 13, 2024
Downloads
29
Citations as of Oct 13, 2024
SCOPUSTM
Citations
25
Citations as of Oct 17, 2024
WEB OF SCIENCETM
Citations
24
Citations as of Oct 17, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.